23rd Jun 2006 07:01
Skyepharma PLC23 June 2006 For Immediate Release 23 June 2006 SkyePharma PLC SKYEPHARMA TO PRESENT AT JEFFERIES LIFE SCIENCES CONFERENCE LONDON, UK, 23 June 2006 -- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announcestoday that the Company's Chief Operating Officer, Dr Ken Cunningham, will make apresentation at the Jefferies Life Sciences Conference on Tuesday, June 27th ,2006 at 9:30 a.m. (ET) at the Mandarin Oriental Hotel, New York. Investors and other interested parties may access a live audio webcast alongwith the slides of this presentation on SkyePharma's website www.skyepharma.comunder the Investor Relations tab. SkyePharma PLC develops pharmaceutical products benefiting from world-leadingdrug delivery technologies that provide easier-to-use and more effective drugformulations. There are now eleven approved and marketed products incorporatingSkyePharma's technologies in the areas of oral, injectable, inhaled and topicaldelivery, supported by advanced solubilisation capabilities. For moreinformation, visit www.skyepharma.com. For further information please contact: SkyePharma PLC +44 207 491 1777Frank Condella, Chief Executive OfficerPeter Laing, Director of Corporate Communications +44 207 491 5124Sandra Haughton, US Investor Relations +1 212 753 5780 Buchanan Communications +44 207 466 5000Tim Anderson / Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L